Acalabrutinib Monotherapy In CLL

Michelle Dawson Franchise Head Hematology, US Medical Affairs at AstraZeneca Discusses Acalabrutinib Monotherapy In CLL At The 60th ASH Annual Meeting on Dec 1, 2018.